Correction: Intramyocardial injected human umbilical cord-derived mesenchymal stem cells (HucMSCs) contribute to the recovery of cardiac function and the migration of CD4+ T cells into the infarcted heart via CCL5/CCR5 signaling
Jing Liu, Xiaoting Liang, Mimi Li, Fang Lin, Xiaoxue Ma, Yuanfeng Xin, Qingshu Meng, Rulin Zhuang, Qingliu Zhang, Wei Han, Ling Gao, Zhiying He, Xiaohui Zhou, Zhongmin Liu
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMesenchymal stem cell research · Cardiac Fibrosis and Remodeling · Tissue Engineering and Regenerative Medicine
Correction: Stem Cell Research & Therapy (2022) 13:247 10.1186/s13287-022-02914-z
Following the publication of the article [1], the authors regretfully found one error in Fig. 1C which was intended to demonstrate the in vivo safety evaluation of HucMSCs. The selection error of the representative image of lung in Fig. 1C occurred during figure preparation.
The authors corrected the mistake and replaced the erroneous image with the correct one which is displayed ahead in this Correction article as the revised Fig. 1C. This unintentional error does not affect the conclusions of this study.